market Research / Analysis Stem Cell Assay Market by Product-converted

Stem Cell Assay Market by Product & Service Global Analysis & Forecast By 2030
Market Industry Reports (MIR) has published a new report titled “Stem Cell Assay Market -
Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2030.”
According to the report the global stem cell assay market was valued at over US$
450.0 Mn. in 2017 and is expected to grow at a double digit CAGR over the
forecast period.
The major factors driving the growth of the market includes increasing burden of chronic diseases,
growing investment in R&D, and technological developments in biotech and pharmaceutical industry.
Browse key industry insights spread across 150 pages with market data tables & figures & charts
from the report, Stem Cell Assay Market by Product & Service (Instruments, Kits) Cell
Type(Adult Stem Cells, Human Embryonic Stem Cells), Application (Regenerative Medicine,
Drug Discovery, Clinical Research), Type (Cell Identification, Viability, Proliferation Assay) -
Global
Analysis
&
Forecast,
2019-2030 in
detail
along
with
the
table
of
contents: https://www.marketindustryreports.com/8/stem-cell-assay-market
ncreasing burden of chronic diseases to boost the market growth
Increasing global burden of diseases such as diabetes, cancer, and others are projected to be the
major factors leading to the market growth. According to the World Health Organization (WHO) in
2017, number of patients suffering from type I and type II diabetes was estimated to be over 422
million. Moreover, the disease is expected to be the seventh largest cause of death by 2030.
According to American Cancer Society, in 2017, there were over 1.6 million new cancer cases in the
U.S. Hence, there exists a need for developing new treatment methods which have led to the rise in
approvals of clinical trials for the stem cell based therapies.
Get Your Free PDF Sample Copy @ https://www.marketindustryreports.com/free-
sample/8
High cost of Stem cell therapy to restrict the market growth
Stem cell transplantation is expensive as being the multiple step process which includes isolating
adult stem cells, diagnosis, re-administering, and post treatment care with follow-ups. Moreover, the
high initial investment due to the high cost of instrument used in developing stem cell therapy is the
major factors restricting the growth of the market. Moreover, not all costs associated with the
treatment are allocated at the time of practice, hidden costs including the graft versus host disease,
reaction to treatment, or disability resulting from the treatment can lead to more costs and additional
treatments.
Major Players in the market focusing on R&D
Key players operating in the global stem cell assay market are Thermo Fisher Scientific, Promega
Corporation, STEMCELL Technologies Inc., Merck KGaA, GE Healthcare, Bio-Techne Corporation,
Hemogenix, Bio-Rad Laboratories, Inc., Cellular Dynamics International Inc., and Cell Biolabs Inc